Back to results
US 2017/0247695 A1Published application
Isotopologues of smad7 antisense oligonucleotides
AssigneeCelgene Corporation
InventorPeter Anthony CICALA
Life of this patent
Estimating the term…
Abstract
This disclosure relates generally to deuterated isotopologues of SMAD7 antisense oligonucleotides, pharmaceutical compositions containing the same, and methods of using the same.
Claims93
A deuterated SMAD7 antisense oligonucleotide, comprising a plurality of hydrogens (H), wherein one or more hydrogens of the plurality of hydrogens are replaced by deuterium (D).
Dependencies are inferred from the claim text.